Fairvalue-Calculator Fairvalue-Calculator
EN DE

INOVIQ Ltd (IIQ) Fair Value & Analysis

Healthcare · AU · Market cap A$47.9M

PriceA$0.5000
Fair ValueA$0.5300
Upside+6.0%
Quality95/100
Evidence: Low Range A$0.4000 – A$0.6700

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

INOVIQ Ltd (IIQ) currently trades at A$0.5000, while our model-based Fair Value estimate is A$0.5300 — implying the stock looks roughly 6.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is INOVIQ Ltd (IIQ) undervalued?
As of Jun 24, 2026, our model estimates a fair value of A$0.5300 versus a price of A$0.5000 — about +6% (undervalued). Model-based estimate, not financial advice.
What is the fair value of IIQ?
Our 21-model fair value for INOVIQ Ltd is A$0.5300 (as of Jun 24, 2026), built from audited fundamentals. The current price is A$0.5000.
What is the quality score of IIQ?
INOVIQ Ltd has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.